Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 23, 2017 – The FDA approved a revision to the indication for Aerospan (flunisolide). Information regarding asthma patients requiring oral corticosteroid therapy was removed.
Return to publications